1.Hoenders R, Bartels-Velthuis A, Vollbehr N, Bruggeman R, Knechtering R, de Jong J. Natural medicines in schizophrenia: a systematic review. Journal of alternative and complementary medicine. 2014;20(5):A79.
2.Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Archives of general psychiatry. 2003;60(12):1187–1192.
3.Mueser KT, McGurk SR. Schizophrenia. Lancet. 2004;363(9426):2063–2072.
4.Heron EA, Cormican P, Donohoe G, et al. No evidence that runs of homozygosity are associated with schizophrenia in an Irish genome-wide association dataset. Schizophrenia research. 2014;154(1–3):79–82.
5.Abi-Dargham A, Moore H. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. The Neuroscientist: a review journal bringing neurobiology, neurology and psychiatry. 2003;9(5):404–416.
6.Fan H, Zhang F, Xu Y, et al. An association study of DRD2 gene polymorphisms with schizophrenia in a Chinese Han population. Neuroscience letters. 2010;477(2):53–56.
7.Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III—the final common pathway. Schizophrenia bulletin. 2009;35(3):549–562.
8.Davis J, Moylan S, Harvey BH, Maes M, Berk M. Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries. The Australian and New Zealand journal of psychiatry. 2014.
9.Yamamoto K, Fontaine R, Pasqualini C, Vernier P. Classification of Dopamine Receptor Genes in Vertebrates: Nine Subtypes in Osteichthyes. Brain, behavior and evolution. 2015;86(3–4):164–175.
10.Sokoloff P, Giros B, Martres MP, et al. Localization and function of the D3 dopamine receptor. Arzneimittel-Forschung. 1992;42(2A):224–230.
11.Yang B, Niu W, Chen S, et al. Association study of dopamine receptor genes polymorphisms with the risk of schizophrenia in the Han Chinese population. Psychiatry research. 2016;245:361–364.
12.Utsunomiya K, Shinkai T, Sakata S, et al. Genetic association between the dopamine D3 receptor gene polymorphism (Ser9Gly) and tardive dyskinesia in patients with schizophrenia: a reevaluation in East Asian populations. Neuroscience letters. 2012;507(1):52–56.
13.Savitz J, Hodgkinson CA, Martin-Soelch C, et al. The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movement. PloS one. 2013;8(1):e54108.
14.Jhun E, He Y, Yao Y, Molokie RE, Wilkie DJ, Wang ZJ. Dopamine D3 receptor Ser9Gly and catechol-o-methyltransferase Val158Met polymorphisms and acute pain in sickle cell disease. Anesthesia and analgesia. 2014;119(5):1201–1207.
15.Chang TT, Chen SL, Chang YH, et al. The DRD3 Ser9Gly Polymorphism Predicted Metabolic Change in Drug-Naive Patients With Bipolar II Disorder. Medicine. 2016;95(24):e3488.
16.Xu S, Liu J, Yang X, Qian Y, Xiao Q. Association of the DRD2 CAn-STR and DRD3 Ser9Gly polymorphisms with Parkinson’s disease and response to dopamine agonists. Journal of the neurological sciences. 2017;372:433–438.
17.Zai CC, Manchia M, Sonderby IE, et al. Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders. The world journal of biological psychiatry: the official journal of the World Federation of Societies of Biological Psychiatry. 2015;16(3):171–179.
18.Crocq MA, Mant R, Asherson P, et al. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. Journal of medical genetics. 1992;29(12):858–860.
19.Nimgaonkar VL, Sanders AR, Ganguli R, et al. Association study of schizophrenia and the dopamine D3 receptor gene locus in two independent samples. American journal of medical genetics. 1996;67(6):505–514.
20.Ayoub N, Jeyasekharan AD, Bernal JA, Venkitaraman AR. HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response. Nature. 2008;453(7195):682–686.
21.Chen CH, Liu MY, Wei FC, Koong FJ, Hwu HG, Hsiao KJ. Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophrenia. American journal of medical genetics. 1997;74(1):40–43.
22.Barlas IO, Cetin M, Erdal ME, et al. Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients. American journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics. 2009;150B(1):56–60.
23.Yao J, Pan YQ, Ding M, Pang H, Wang BJ. Association between DRD2 (rs1799732 and rs1801028) and ANKK1 (rs1800497) polymorphisms and schizophrenia: a meta-analysis. American journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics. 2015;168B(1):1–13.
24.Lanara Z, Giannopoulou E, Fullen M, et al. Comparative study and meta-analysis of meta-analysis studies for the correlation of genomic markers with early cancer detection. Human genomics. 2013;7:14.
25.Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. Journal of epidemiology and community health. 2013;67(11):974–978.
26.Williams J, Spurlock G, Holmans P, et al. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Molecular psychiatry. 1998;3(2):141–149.
27.Dubertret C, Gorwood P, Ades J, Feingold J, Schwartz JC, Sokoloff P. Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians. American journal of medical genetics. 1998;81(4):318–322.
28.Jonsson EG, Flyckt L, Burgert E, et al. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatric genetics. 2003;13(1):1–12.
29.Jonsson EG, Kaiser R, Brockmoller J, Nimgaonkar VL, Crocq MA. Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia. Psychiatric genetics. 2004;14(1):9–12.
30.Utsunomiya K, Shinkai T, De Luca V, et al. Genetic association between the dopamine D3 gene polymorphism (Ser9Gly) and schizophrenia in Japanese populations: evidence from a case-control study and meta-analysis. Neuroscience letters. 2008;444(2):161–165.
31.Nunokawa A, Watanabe Y, Kaneko N, et al. The dopamine D3 receptor (DRD3) gene and risk of schizophrenia: case-control studies and an updated meta-analysis. Schizophrenia research. 2010;116(1):61–67.
32.Qi XL, Xuan JF, Xing JX, Wang BJ, Yao J. No association between dopamine D3 receptor gene Ser9Gly polymorphism (rs6280) and risk of schizophrenia: an updated meta-analysis. Neuropsychiatric disease and treatment. 2017;13:2855–2865.
33.Yang Z, Thomas DC. Two-stage family-based designs for sequencing studies. BMC proceedings. 2014;8(Suppl 1):S32.
34.Yang B, Chan RC, Jing J, Li T, Sham P, Chen RY. A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3’-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. American journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics. 2007;144B(4):541–550.
35.Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003;327(7414):557–560.
36.Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genetic epidemiology. 2005;28(2):123–137.
37.Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in medicine. 2002;21(11):1539–1558.
38.Leonard T, Duffy JC. A Bayesian fixed effects analysis of the Mantel-Haenszel model applied to meta-analysis. Statistics in medicine. 2002;21(16):2295–2312.
39.Macciardi F, Verga M, Kennedy JL, et al. An association study between schizophrenia and the dopamine receptor genes DRD3 and DRD4 using haplotype relative risk. Human heredity. 1994;44(6):328–336.
40.Rothschild LG, Badner J, Cravchik A, Gershon ES, Gejman PV. No association detected between a D3 receptor gene-expressed variant and schizophrenia. American journal of medical genetics. 1996;67(2):232–234.
41.Malhotra AK, Goldman D, Buchanan RW, et al. The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response. Molecular psychiatry. 1998;3(1):72–75.
42.Kalsi G, Curtis D, Brynjolfsson J, et al. Tests of linkage, allelic and genotypic association between schizophrenia and the gene for the D3 dopamine receptor, DRD3. Psychiatric genetics. 1998;8(3):187–189.
43.Ambrosio AM, Kennedy JL, Macciardi F, et al. Family association study between DRD2 and DRD3 gene polymorphisms and schizophrenia in a Portuguese population. Psychiatry research. 2004;125(3):185–191.
44.Luxian Lu HZ, Suqin Guo, Yuzhong Shi. Association between DRD3 gene Ser9Gly polymorphism and schizophrenia in center families. Journal of Fourth Military Medical University. 2005;26(24):2261–2264.
45.Yuhong Wang YS, Luixan Lu, et al. Association of dopamine D3 receptor Ser9Gly polymorphism with schizophrenia. Journal of Clinical Psychology Medicine. 2006;16(1):38–39.
46.Talkowski ME, Mansour H, Chowdari KV, et al. Novel, replicated associations between dopamine D3 receptor gene polymorphisms and schizophrenia in two independent samples. Biological psychiatry. 2006;60(6):570–577.
47.Pawel K, Hauser J, Skibinska M, et al. [Family based association study of DRD1, DRD2, DRD3, DRD4, DAT, COMT gene polymorphism in schizophrenia]. Psychiatria polska. 2010;44(3):405–413.
48.Prasad S, Deshpande SN, Bhatia T, Wood J, Nimgaonkar VL, Thelma BK. Association study of schizophrenia among Indian families. American journal of medical genetics. 1999;88(4):298–300.
49.Kremer I, Rietschel M, Dobrusin M, et al. No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population. American journal of medical genetics. 2000;96(6):778–780.
50.Zai CC, Manchia M, De Luca V, et al. Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case-control and family based study designs. Progress in neuro-psychopharmacology & biological psychiatry. 2010;34(8):1412–1418.
51.Ma G, He Z, Fang W, et al. The Ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: an association study and a large meta-analysis. Schizophrenia research. 2008;101(1–3):26–35.
52.Haldar T, Ghosh S. Statistical equivalent of the classical TDT for quantitative traits and multivariate phenotypes. J Genet. 2015;94(4):619–628.
53.Leung PW, Chan JK, Chen LH, et al. Family-based association study of DRD4 gene in methylphenidate-responded Attention Deficit/Hyperactivity Disorder. PLoS One. 2017;12(3):e0173748.